Trial Details

COMPLETED
Basic Information
Clinical ID c1783
Identifier NCT02531113
Trial Title Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: RPC1063
Participant Information
Sponsor Celgene
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-10-09
Primary Completion Date 2019-09-12
Completion Date 2019-11-28